跳至主要内容
临床试验/NCT01635530
NCT01635530已完成4 期

Study of Lyme Neuroborreliosis: Epidemiology, Manifestations, Diagnostics and Treatment

Turku University Hospital2 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
210
试验地点
2
主要终点
The improvement of the clinical condition during the study.

研究概览

简要总结

The main purpose of this study is to determine whether four weeks treatment with oral doxycycline is as equally effective as three weeks treatment with intravenous ceftriaxone in patients with Lyme neuroborreliosis. The other purpose is to improve laboratory diagnostics of Lyme neuroborreliosis and further define the manifestations and epidemiology of the disease in Finland.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • pregnancy and breastfeeding
  • women planning to get pregnant in two months
  • age under 18
  • handicapped persons
  • prisoners
  • use of any antibiotics two weeks before study treatments begins
  • allergy for tetracyclines or cephalosporins

研究组 & 干预措施

Ceftriaxone

Active Comparator

Treatment of intravenous ceftriaxone (2 g/day), three weeks

干预措施: Ceftriaxone (Drug)

Doxycycline

Experimental

Treatment with oral doxycycline (200mg / day), four weeks

干预措施: Doxycycline (Drug)

结局指标

主要结局

The improvement of the clinical condition during the study.

时间窗: 12 months

The clinical condition of participants will be evaluated with visual analogue scale (from 0 to 10, 0=best) by the participants. The VAS scores are collected before the treatment with antibiotics, and 4 months and 12 months after the treatment.

The clinical condition evaluated by the participants after 12 months from the treatment

时间窗: 12 months

The clinical condition is evaluated with VAS by the participants.

次要结局

  • Central spinal fluid (CSF) pleocytosis(3 weeks)
  • CSF protein concentration(3 weeks)
  • CSF CXCL13 concentration(3 weeks)
  • CSF lactate level(3 weeks)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Jarmo Oksi

vs.prof

Turku University Hospital

研究点 (2)

Loading locations...

相似试验